Search results
US FDA advisers to consider if new COVID shots should target JN.1 variant
Reuters via Yahoo News· 7 hours agoShares of Novavax soared 11% in morning trade, after the documents were released. The company had...
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena via Yahoo Finance· 12 hours agoMSD released positive data from Phase II and III trials for its ADC therapy, sacituzumab...
Thousands of NHS patients to trial new personalised cancer vaccine in ‘landmark moment’
The Independent via Yahoo News· 4 days agoThe vaccine was created using mRNA technology – the same used in Covid jabs – and is being jointly...
Six cancer treatment breakthroughs pushing us closer to a cure
The Telegraph via Yahoo News· 3 days agoIn July last year, the Government signed an agreement with the pharma company to provide up to...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 2 days agoGenmab A/S (Nasdaq: GMAB, “Genmab”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced initial data from the ongoing Phase 2 trial (NCT05117242) ...
Pfizer says tweaked COVID-19 shots boost omicron protection
KRGV Rio Grande Valley· 5 days agoPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is...
Thousands of cancer patients to trial personalised vaccines
BBC via Yahoo News· 4 days agoSo he signed up to a trial of an investigational vaccine made by German pharma company BioNTech,...
US FDA advisers to consider if new COVID shots should target JN.1 variant By Reuters
Investing.com· 7 hours agoShares of Novavax (NASDAQ:NVAX) soared 11% in morning trade, after the documents were released. The...
NHS England launches pioneering trials for world-first cancer vaccine
BioPharma-Reporter· 11 hours agoTo date, thirty hospitals have joined NHS England's Cancer Vaccine Launch Pad, which aims to...
What the EU Has Done for Us | by Nadia Calviño - Project Syndicate
Project Syndicate· 6 hours agoThis month, hundreds of millions of voters will head to the polls for the European Parliament...
